CORC

浏览/检索结果: 共56条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:  Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei
收藏  |  浏览/下载:26/0  |  提交时间:2020/11/26
Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate 期刊论文
FASEB JOURNAL, 2020, 页码: 18
作者:  Hait, Nitai C.;  Maiti, Aparna;  Xu, Pan;  Qi, Qianya;  Kawaguchi, Tsutomu
收藏  |  浏览/下载:43/0  |  提交时间:2020/07/01
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis 期刊论文
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:  Fang, Xiaona;  Xie, Hua;  Luo, Min;  Chen, Zhen;  Wang, Fang
收藏  |  浏览/下载:34/0  |  提交时间:2019/01/08
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor 期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:  Xie, Chengying;  Wan, Xiaozhe;  Quan, Haitian;  Zheng, Mingyue;  Fu, Li
收藏  |  浏览/下载:43/0  |  提交时间:2019/01/08
VEGF-A regulates sFlt-1 production in trophoblasts through both Flt-1 and KDR receptors. 期刊论文
Molecular and Cellular Biochemistry, 2018
作者:  Zhong-Lin Xiao;  Songjun Li;  Yan Yu;  Mengxia Li;  Jie Chen
收藏  |  浏览/下载:31/0  |  提交时间:2019/01/31
Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization 期刊论文
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 卷号: 20, 期号: 5
作者:  Zhu, L.;  Liu, R.;  Zhang, W.;  Qian, S.;  Wang, J.
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Broad targeting of triptolide to resistance and sensitization for cancer therapy 期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, 卷号: 104, 页码: 771-780
作者:  Hou, Zhen-yan;  Tong, Xiao-pei;  Peng, Yong-bo;  Zhang, Bi-Kui*;  Yan, Miao*
收藏  |  浏览/下载:50/0  |  提交时间:2019/12/03
ABC  ATP-binding cassette  AKT  V-Akt murine thymoma viral oncogene homolog  ALDH1  aldehyde dehydrogenase 1  AR  androgen receptor  Bad  Bcl-2-associated death promoter  Bak  Bcl-2 homologous antagonist killer  Bax  Bcl-2-associated X protein  Bcl-2  B-cell lymphoma  Bcl-xL  Bcl-extra large  Bcl-xs  Bcl-extra short  BCRP  breast cancer resistance protein  Bid  BH3 interacting domain death agonist  Bik  Bcl-2-interacting killer  BNIP3  Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3  CAF  cancer-associated fibroblast  CAIX  carbonic anhydrase IX  cFLIP  cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein  ChIP  chromatin immunoprecipitation  CI  Combination Index  cIAP1/2  cellular IAP1/2  CML  chronic myelogenous leukemia  CSC  cancer stem cell  DISC  death-inducing signaling complex  DR  death receptor  DRI  Dose Reduction Index  ECM  extracellular matrix  EMT  epithelial-mesenchymal transition  EpCAM  epithelial cell adhesion molecule  GLUT  glucose transporter  GSK3β  glycogen synthase kinase-3β  HIF-1  hypoxia inducible factor-1  HSF1  heat shock factor 1  HSP  heat shock protein  IAP  inhibitor of apoptosis protein  JNK  c-JUN N-terminal kinase  MAPK  mitogen-activated protein kinase  Mcl-1  myeloid leukemia cell differentiation protein  MDM2  murine double minute 2  MDR  multidrug resistance  MKP  MAPK phosphatase  MRP1  multidrug resistance protein 1  NF-κB  nuclear factor-kappaB  pAkt  phosphor-Akt  PARP  poly ADP-ribose polymerase  P-gp  P-glycoprotein  PI3K-PTEN  phosphatidylinositol 3-kinase-phosphatase and tensin homolog  PKC  phosphorylated at Ser9 by protein kinase C  pp2A  protein phosphatase 2A  REST  repressor element-1 silencing transcription factor  SAR  structure-activity relationship  TAM  tumor-associated macrophage  TFIIH  transcription factor IIH  TKI  tyrosine kinase inhibitor  TM  tumor-microenvironment  TRAIL/Apo-2L  TNF-related apoptosis-inducing ligand  tRXRα  the N-terminal truncated form of the nuclear retinoid X receptor-α  TWHF  Tripterygium wilfordii Hook F  VEGF  vascular endothelial growth factor  XIAP  X-linked IAP  XPB  xerodermapigmentosum group B protein  Triptolide  Antineoplastic  Resistance  Sensitization  Mechanism  
Nanosecond Pulsed Electric Fields Enhance the Anti-tumour Effects of the mTOR Inhibitor Everolimus against Melanoma 期刊论文
SCIENTIFIC REPORTS, 2017
Dai, Jie; Wu, Shan; Kong, Yan; Chi, Zhihong; Si, Lu; Sheng, Xinan; Cui, Chuanliang; Fang, Jing; Zhang, Jue; Guo, Jun
收藏  |  浏览/下载:5/0  |  提交时间:2017/12/03
Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling 期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 50, 页码: 82820-82835
作者:  Zhou, Xunian;  Yue, Grace Gar-Lee;  Liu, Minghua;  Zuo, Zhili;  Lee, Julia Kin-Ming
收藏  |  浏览/下载:244/0  |  提交时间:2017/02/28
Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation 期刊论文
CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 卷号: 87, 期号: 5, 页码: 694-703
作者:  Yan, Wei;  Huang, Zhaoru;  Wang, Zhengyu;  Cao, Sufen;  Tong, Linjiang
收藏  |  浏览/下载:31/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace